OnCo
ideasIdea

Prove your cell lines are what you say they are, or the paper is not published

A large share of cancer research has been done on cells that were mislabelled or contaminated. A cheap DNA fingerprint test can prove identity; journals and funders should require it.

Cross-contaminated and misidentified cell lines (the ICLAC register lists over 500) continue to be used in thousands of papers. Short tandem repeat profiling costs under a hundred dollars per line. Some journals and NIH recommend authentication; few enforce it. A mandate that every paper and grant using cell lines deposits a recent STR profile matched to Cellosaurus, with funders covering the cost, would close a known, fixable source of irreproducibility.

Hypothesis
Enforcement at ten major journals and two funders reduces the share of new oncology papers using known misidentified lines from the several percent found in audits to under 0.5% within three years.
Rationale
The problem is fully characterised, the test is cheap and standardised (ANSI/ATCC ASN-0002), and enforcement is the only missing element.
What would test it
Adopt the mandate at participating journals; audit a random sample of published papers annually for compliance and for use of misidentified lines.
Maturity
early clinical
Who has to act
policy
Cost to try
Small (under $1M)
Years to first evidence
1
Bottlenecks it attacks

Connected

4top

Pages like this

not linked directly; found by shared links